Tokyo Future Style
- Company typePrivate
- Founded2007
- HeadquartersTsukuba, Japan
- Headcount1–10
- GTM typeB2B
- OfferingServices
Tokyo Future Style firmographics
Firmographics- Name
- Tokyo Future Style
- Legal name
- 株式会社東京未来スタイル
- Website
- https://tokyofuturestyle.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where Tokyo Future Style is headquartered
LocationHeadquarters
- HQ city
- Tsukuba
- HQ country
- Japan
- HQ region
- Asia
Offices3 records
Markets served
Tokyo Future Style business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Research reagent import and distribution: Tokyo Future Style operates as a life science trading company, importing and distributing research reagents, antibodies, recombinant proteins, ELISA kits, magnetic beads, cell tracking reagents, and clinical samples from global biotech suppliers to Japanese and Asian research institutions. Revenue is generated through product sales, distribution agreements, and trading/import-export services.
- Custom synthesis and research services: The company offers custom synthesis services and research outsourcing, including procurement of specialized research materials. Revenue is generated through service fees.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Tokyo Future Style product offering
Product offeringCore offering
Tokyo Future Style is a life science trading company that imports and distributes research reagents, antibodies, recombinant proteins, ELISA kits, magnetic beads, cell tracking reagents, and human clinical samples from global biotech suppliers to research institutions across Japan, Taiwan, and Europe. The company also offers custom synthesis services, research material procurement, and contract research support, acting as an intermediary between Western/Asian bio-venture suppliers and Japanese/Asian life science customers.
Product overview
Tokyo Future Style is a life science trading company that imports and distributes research reagents, materials, and custom services from global biotech suppliers. The company operates a multi-product portfolio organized into eight main categories: infectious disease, cancer research, regenerative medicine, drug discovery, life science products, NAMs (New Approach Methodologies), human clinical samples, and custom synthesis services. Key branded products include LuminX Tracking Kits for fluorescent nanodiamond-based in vivo cell tracking, and MAGicBeads/MAGicSep magnetic bead purification and separation systems. The company also distributes products from over 20 international suppliers including ACROBiosystems, ICE Bioscience, Abbexa, and SinoBiological. Services include research material procurement, custom synthesis, and contract research support across Japan, Taiwan, and Europe.
Differentiator
Problem solved
Functional benefit
Products and services
- LuminX Tracking Kit (LTK) Fluorescent nanodiamond-based cell tracking kit using proprietary XTag technology for in vivo tracking of MSC, iPSC, T cells, NK cells, and cancer cells. Designed for life science researchers and cell therapy developers.
- MAGicBeads Magnetic Beads Magnetic agarose beads for antibody purification and cell separation, including MAGicBeads mAb (alkali-resistant Protein A), MAGicBeads PrtA, MAGicBeads SerA, and MAGicBeads ACT (activated beads for custom coupling). For bioprocessing and antibody research customers.
- MAGicSep Magnetic Separators Magnetic separation devices including MAGicSep LAB, PILOT (50/500), and PROCESS (Compact/Medio/Maxi) units for lab to process-scale throughput. Targeted at bioprocessing and antibody production customers.
- Custom Synthesis and Contract Research Services Contract research services including custom synthesis of compounds, custom magnetic bead development, and outsourced laboratory services for life science researchers and pharmaceutical/biotech companies.
- Research Material Procurement Service Sourcing and procurement service for specialized research reagents and materials from global biotech suppliers on behalf of Japanese and Asian research institutions. Includes logistics, regulatory navigation, and translation support for cross-border procurement.
- EMARS Reagent Ar-Flu Research reagent that enables detection of molecular interactions on living cell membranes with high selectivity and improved detection efficiency through HRP reaction. Targeted at academic and industrial life science researchers studying cell surface interactions.
Companies that use Tokyo Future Style
Customer profileSegments2 records
Ideal customer profiles2 records
Tokyo Future Style technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Tokyo Future Style partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor, core and major.
- Finnadvance (MPS device AKITA and NAMs related products)minorTokyo Future Style showcases Finnadvance's MPS (Microphysiological Systems) device AKITA and NAMs-related products at the MPS Council 3rd Academic Symposium (January 2025).
- Netguard Technology Co., Ltd. (網護科技)coreTokyo Future Style and Netguard Technology Co., Ltd. established a joint venture company in Taiwan in January 2019. The joint venture aims to provide import services for products suitable for the Taiwanese biological research market and export services for Taiwanese companies' products to global markets.
- TFS Europe B.V.coreTFS Europe B.V. is a 100% subsidiary of Tokyo Future Style established in Nijmegen, the Netherlands, in April 2017. It serves as the company's European hub for import/export of life science research materials.
- Radboud University Medical Center (Nijmegen, Netherlands)majorTokyo Future Style signed a distribution agreement with Radboud University Medical Center for Japan and Taiwan. The agreement covers transporter assay and drug toxicity screening applications using human renal cell lines developed by the university.
- TropIQ Health Sciences (Netherlands)majorTokyo Future Style signed a distribution agreement for Japan and Taiwan with TropIQ Health Sciences, a Dutch bio-venture company. The agreement covers novel technologies useful for anti-malaria drug development and insecticide development.
- UAB Ferentis (Lithuania)majorTokyo Future Style signed a distribution agreement for Japan with UAB Ferentis, a Lithuanian bio-venture company, to distribute the company's hydrogel-related products.
- KromaTiD (USA)majorTokyo Future Style signed a distribution agreement with KromaTiD, a US chromosomal/genetic testing venture company, to distribute their products in Japan.
Scale indicators1 record
Recent moves10 records
Expansion highlights5 records
Tokyo Future Style competitors and assessment
Company assessmentDirect peers
- Funakoshi Co., Ltd. Japanese life science reagent distributor/trading company importing research reagents, antibodies, and kits to Japanese researchers. Direct comparable to TFS in business model, customer base (Japanese academic/biotech R&D), and catalog breadth.
- Nacalai Tesque, Inc. Kyoto-based Japanese life sciences reagent manufacturer and distributor serving academic and biotech researchers in Japan. Comparable to TFS in its reagent distribution and import activities for research customers.
- ACROBiosystems: China/US-headquartered recombinant protein and reagent supplier using HEK293 platform. Distributed by TFS in Japan; comparable as an Asian bio-venture reagent supplier with overlapping catalog in drug discovery and cell therapy reagents.
- Sino Biological, Inc. Beijing-headquartered recombinant protein and antibody supplier for research use. TFS actually distributes SinoBiological products in Japan/Taiwan, making them a key supplier relationship; comparable as a global bio-venture reagent company targeting Asian research customers.
- Cosmo Bio Co., Ltd. Tokyo-based life science reagent distributor serving Japanese research institutions with imported and proprietary products. Closest direct peer to TFS given shared Japanese customer base, import/distribution model, and reagent portfolio focus.
- GenScript Biotech: Global biotech with strong presence in Asia providing gene synthesis, proteins, antibodies, and cell therapy services. Comparable to TFS given Asian orientation and life science research product portfolio serving biotech R&D customers.
Broad incumbents
- Thermo Fisher Scientific: Global life science tools and reagent giant with extensive catalog and direct Japanese operations. Overlaps with TFS in reagent distribution to Japanese researchers but at vastly larger scale and broader offering.
- FUJIFILM Wako Pure Chemical: Major Japanese chemical and reagent brand serving life science research with a much broader catalog and scale. Overlaps with TFS in life science reagent distribution in Japan but operates as a much larger established player with manufacturing capabilities.
- Bio-Techne Corporation: Large global life science reagent, antibody, and protein supplier (R&D Systems, Tocris, ProteinSimple brands). Overlaps with TFS in reagents/antibodies/proteins distribution but operates at vastly greater scale and across broader geographies.
- Bio-Rad Laboratories: Global life science research and clinical diagnostics company with significant reagent offering. Comparable to TFS in protein/antibody/reagent distribution to researchers but at broader scale and with product manufacturing rather than pure trading.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Tokyo Future Style social profiles
Digital presenceTokyo Future Style financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tokyo Future Style leadership team
Management profileNumber of profiles
Profiles1 record
Tokyo Future Style subsidiaries and ownership
Company hierarchySubsidiaries2 records
Tokyo Future Style funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tokyo Future Style M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tokyo Future Style
What does Tokyo Future Style do?
Tokyo Future Style is a life science trading company that imports and distributes research reagents, antibodies, recombinant proteins, ELISA kits, magnetic beads, cell tracking reagents, and human clinical samples from global biotech suppliers to research institutions across Japan, Taiwan, and Europe. The company also offers custom synthesis services, research material procurement, and contract research support, acting as an intermediary between Western/Asian bio-venture suppliers and Japanese/Asian life science customers.
Is Tokyo Future Style a public or private company?
Tokyo Future Style is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Tokyo Future Style founded?
Tokyo Future Style was founded in 2007. It employs 1 to 10 people.
Where is Tokyo Future Style based?
Tokyo Future Style is headquartered in Tsukuba, Japan, in the Asia region.
How does Tokyo Future Style make money?
Two revenue lines are on record. Research reagent import and distribution is the primary driver. The others are custom synthesis and research services.
Who are Tokyo Future Style's main competitors?
Direct peers on record are Funakoshi Co., Ltd., Nacalai Tesque, Inc., ACROBiosystems, Sino Biological, Inc., Cosmo Bio Co., Ltd. and GenScript Biotech. Broad incumbents are Thermo Fisher Scientific, FUJIFILM Wako Pure Chemical, Bio-Techne Corporation and Bio-Rad Laboratories.
Does Tokyo Future Style have an API?
No public API is recorded for Tokyo Future Style.